At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
enLighten Laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Open-Label Comparison Study of Picosecond and Nanosecond Pulse Durations Using a Q-switched Nd:YAG Laser for Tattoo Removal
In Brief
A clinical study evaluating enLighten Laser for Tattoo Removal. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the safety and efficacy of laser tattoo removal with picosecond pulse durations as compared to treatment with nanosecond pulse durations using a single novel Q-Switched (QS) Nd:YAG laser.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTattoo Removal
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJul 2014
First PostedSep 2014
Primary CompletionMar 2016
TodayJul 2026
First PostedSep 19, 2014
Enrollment StartJul 1, 2014
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 11.8 years ago
Interventions
enLighten Laserdevice
Picosecond pulse-duration or Nanosecond pulse-duration tattoo treatment with enLighten Q-switched Laser Treatment